ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Max-Bio Biosciences acquired 21,42,857 shares (11.89% stake) in Raconteur Global Resources via preferential allotment. The non-promoter acquirer held no prior stake in the company.
Raconteur Global Resources allotted 47,49,999 equity shares at ₹14 each upon conversion of warrants to non-promoter investors. Total issue value is approximately ₹6.65 Crore.
Raconteur Global Resources' board approved calling upon warrant holders for the balance 75% payment on outstanding warrants to facilitate conversion into equity shares.
Raconteur Global Resources Ltd approved a preferential issue of warrants and equity shares, aggregating approximately ₹30 Crore. The board also approved the Director's Report.